Cerebain Biotech (CBBT) Stock Price, News & Analysis

Company Overview

Cerebain Biotech Corp. is a biotechnology company focused on identifying, acquiring and developing medical technologies intended to address neurodegenerative diseases, particularly Alzheimer’s disease. The company has been described as a development-stage business rather than a commercialized pharmaceutical or medical-device provider.

Historically, Cerebain Biotech has explored intellectual property and potential therapeutic approaches related to Alzheimer’s disease and other neurological conditions. Publicly available information about its product pipeline, clinical development, regulatory status and commercial operations is limited, and the company’s materials do not provide evidence of a widely marketed product or established healthcare service.

Cerebain Biotech is associated with the over-the-counter market under the symbol CBBT. Detailed, current information about its operating geographies, executive leadership and ongoing programs is limited in publicly available sources.

Key Stats

• Today's Range: $0.0008 to $0.0010
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.47
• Volume: 2.04 million shs
• Average Volume: 11.21 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Industrials
• Industry: Trading Companies & Distributors
• Sub-Industry: Trading Companies & Distributors
• Current Symbol: OTCMKTS:CBBT
• CIK: N/A
• Web: www.cerebain.com
• Phone: (714) 371-4109
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A